Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Cavo

Showing results (101-110 of 142) with videos related to

Pageof 15
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2000
Molecular remission after allogeneic or autologous transplantation of hematopoietic stem cells for multiple myelomaG Martinelli, C Terragna, E Zamagni, et al.
Haematologica|September 12, 2000
Polymerase chain reaction-based detection of minimal residual disease in multiple myeloma patients receiving allogeneic stem cell transplantationG Martinelli, C Terragna, E Zamagni, et al.
Leukemia|March 25, 2015
Mutations and long-term outcome of 217 young patients with essential thrombocythemia or early primary myelofibrosisF Palandri, R Latagliata, N Polverelli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 9, 2022
Corrigendum to "Corrigendum to 'Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up'": [Ann Oncol Volume 33, Issue 1, January 2022, Page 117]M A Dimopoulos, P Moreau, E Terpos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 3, 2021
Corrigendum to 'Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up': [Ann Oncol 2021; 32(3): 309-322]M A Dimopoulos, P Moreau, E Terpos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 7, 2021
Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up<sup>†</sup>M A Dimopoulos, P Moreau, E Terpos, et al.
Acta Gastroenterologica Latinoamericana|January 1, 1997
[Hepatitis A virus infection in children in Argentina: a pilot study]J Gonzalez, O Fay, M C Canero-Velasco, et al.
European Journal of Haematology|March 11, 2026
Positioning of Melflufen in Heavily Pretreated RRMM Patients: Real-World Evidence in a Rapidly Evolving Therapeutic LandscapeK Mancuso, S Masci, M Talarico, et al.
Leukemia|April 15, 2016
Opposite activation of the Hedgehog pathway in CD138+ plasma cells and CD138-CD19+ B cells identifies two subgroups of patients with multiple myeloma and different prognosisM Martello, D Remondini, E Borsi, et al.
Blood Cancer Journal|January 27, 2022
Clonal and subclonal TP53 molecular impairment is associated with prognosis and progression in multiple myelomaM Martello, A Poletti, E Borsi, et al.
Pageof 15

Showing results (101-110 of 142) with videos related to

Sort By:
Pageof 15
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2000
Molecular remission after allogeneic or autologous transplantation of hematopoietic stem cells for multiple myelomaG Martinelli, C Terragna, E Zamagni, et al.
Haematologica|September 12, 2000
Polymerase chain reaction-based detection of minimal residual disease in multiple myeloma patients receiving allogeneic stem cell transplantationG Martinelli, C Terragna, E Zamagni, et al.
Leukemia|March 25, 2015
Mutations and long-term outcome of 217 young patients with essential thrombocythemia or early primary myelofibrosisF Palandri, R Latagliata, N Polverelli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 9, 2022
Corrigendum to "Corrigendum to 'Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up'": [Ann Oncol Volume 33, Issue 1, January 2022, Page 117]M A Dimopoulos, P Moreau, E Terpos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 3, 2021
Corrigendum to 'Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up': [Ann Oncol 2021; 32(3): 309-322]M A Dimopoulos, P Moreau, E Terpos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 7, 2021
Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up<sup>†</sup>M A Dimopoulos, P Moreau, E Terpos, et al.
Acta Gastroenterologica Latinoamericana|January 1, 1997
[Hepatitis A virus infection in children in Argentina: a pilot study]J Gonzalez, O Fay, M C Canero-Velasco, et al.
European Journal of Haematology|March 11, 2026
Positioning of Melflufen in Heavily Pretreated RRMM Patients: Real-World Evidence in a Rapidly Evolving Therapeutic LandscapeK Mancuso, S Masci, M Talarico, et al.
Leukemia|April 15, 2016
Opposite activation of the Hedgehog pathway in CD138+ plasma cells and CD138-CD19+ B cells identifies two subgroups of patients with multiple myeloma and different prognosisM Martello, D Remondini, E Borsi, et al.
Blood Cancer Journal|January 27, 2022
Clonal and subclonal TP53 molecular impairment is associated with prognosis and progression in multiple myelomaM Martello, A Poletti, E Borsi, et al.
Pageof 15